Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether the combination of Hycamtin (Topotecan) and
Temozolomide is effective in the treatment of relapsed and refractory neuroblastoma and other
paediatric solid tumors.
Phase:
Phase 2
Details
Lead Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Collaborators:
Catholic University of the Sacred Heart Erasmus Medical Center St. Anna Kinderkrebsforschung